Barrington Sticks to Its Buy Rating for Cimpress (CMPR)

By Ryan Adsit

In a report released today, Kevin Steinke from Barrington maintained a Buy rating on Cimpress (CMPRResearch Report), with a price target of $135. The company’s shares closed yesterday at $119.39.

Steinke said:

“We anticipate that the acquisition of BuildASign, completed on October 2, 2018, will contribute four to five percentage points to year‐over‐year revenue growth in Q2/19. We expect currency translation to result in a revenue growth headwind modestly greater than the one percentage‐point headwind the company experienced in Q1/19.”

According to TipRanks.com, Steinke is a 1-star analyst with an average return of -2.3% and a 46.5% success rate. Steinke covers the Services sector, focusing on stocks such as Cross Country Healthcare, Heidrick & Struggles, and Navigant Consulting.

Currently, the analyst consensus on Cimpress is a Hold with an average price target of $127.

See today’s analyst top recommended stocks >>

Cimpress’ market cap is currently $3.69B and has a P/E ratio of 678.35. The company has a Price to Book ratio of 44.92.

Based on the recent corporate insider activity of 34 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CMPR in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cimpress NV engages in the provision of printing services. Its activities include manufacture and sale customized orders of print, signage, apparel, and similar products. It operates through the following segments: Vistaprint; Upload and Print; National Pen; and All Ither Businesses. The Vistaprint segment focuses in the web bvusiness operation.